Fundacio Institut Guttmann

The Fundacio Institut Guttmann in Badalona is advancing treatments for stroke and traumatic spinal cord injury, with a focus on restoring function and enhancing patient independence through novel cellular and neurostimulation strategies.

• Intrathecal infusion of Wharton's jelly‑derived mesenchymal stem cells
• Transcutaneous spinal cord stimulation (tSCS) combined with intensive neurorehabilitation
• Evaluation of safety, adherence and practical feasibility in chronic spinal cord injury
• Use of the CB1 antagonist rimonabant to improve functional recovery in subacute stroke
• Monitoring of motor, sensory and autonomic outcomes with validated scales

The research team is testing how regenerative cell therapy, targeted electrical stimulation, and pharmacological modulation can together accelerate recovery and support long‑term independence for patients with severe nervous system injuries.